OTCMKTS:GBLX GB Sciences (GBLX) Stock Price, News & Analysis $0.0003 0.00 (0.00%) As of 05/22/2026 03:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About GB Sciences Stock (OTCMKTS:GBLX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GB Sciences alerts:Sign Up Key Stats Today's Range$0.0003▼$0.000350-Day Range N/A52-Week Range$0.0001▼$0.0080Volume299,073 shsAverage Volume38,922 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GB Sciences, Inc. is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety. The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies. GB Sciences has secured licenses for cannabis cultivation and product manufacturing in Panama, positioning the company to serve markets across North and Central America. Its product pipeline includes preclinical and early-stage clinical candidates, as well as formulations designed for future human trials in key therapeutic areas. GB Sciences’ leadership team combines expertise in pharmaceutical development, botanical extraction and regulatory compliance. The company is led by President and Chief Executive Officer Dr. Federico Narváez, MD, whose background spans clinical research and drug development. Supported by scientific and operational executives, GB Sciences continues to pursue strategic collaborations and patent-protected innovations aimed at translating cannabinoid science into meaningful medical treatments.AI Generated. May Contain Errors. Read More Receive GBLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GBLX Stock News HeadlinesGB Sciences Inc.March 27, 2026 | barrons.comGB Sciences Delays Filing of Quarterly ReportNovember 19, 2025 | tipranks.comThe SpaceX filing is public. The window is closing.SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price. | Behind the Markets (Ad)GB Sciences Delays Filing of Quarterly ReportOctober 17, 2025 | tipranks.comGB Sciences, Inc. (GBLX) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comGB Sciences Reports Delay in Quarterly FilingFebruary 12, 2025 | tipranks.comGB Sciences, Inc. (GBLX) stock forecast and price targetJanuary 25, 2025 | finance.yahoo.comGB Sciences Inc (GBLX)August 23, 2024 | investing.comSee More Headlines GBLX Stock Analysis - Frequently Asked Questions How have GBLX shares performed this year? GB Sciences' stock was trading at $0.0005 at the beginning of 2026. Since then, GBLX shares have decreased by 40.0% and is now trading at $0.0003. How were GB Sciences' earnings last quarter? GB Sciences, Inc. (OTCMKTS:GBLX) posted its quarterly earnings data on Monday, November, 14th. The company reported ($0.04) EPS for the quarter. How do I buy shares of GB Sciences? Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GB Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include Canopy Growth (CGC), 22nd Century Group (XXII), NVIDIA (NVDA), Unrivaled Brands (TRTC), TREES (CANN), Aurora Cannabis (ACB) and Meta Platforms (META). Company Calendar Last Earnings11/14/2016Today5/26/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolOTCMKTS:GBLX CIK1165320 Webgbsciences.com Phone(866) 721-0297FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:GBLX) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredTrump Admin to Pump $1 Billion into this “Off-the-Radar” AI StockThe U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...InvestorPlace | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredGold surged 600 dollars last time this indicator peakedThe Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GB Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GB Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
